Cite
MLA Citation
Adam Kaplan et al.. “Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients.” Canadian journal of infectious diseases & medical microbiology =, vol. 2020, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100112672513.0x000027